Abstract
The calcium-activated potassium channel (K Ca channel) activator, NS1619, has been shown to selectively and time-dependently increase the permeability of the blood–tumor barrier (BTB) by downregulating the expression of tight junction (TJ) protein. However, the role of signaling cascades in this process has not been precisely elucidated. This study was performed to determine the role of signaling cascades involving reactive oxygen species (ROS)/RhoA/PI3K/PKB in increasing the permeability of the BTB induced by NS1619. Using an in vitro BTB model and selective inhibitors of signaling pathways, we investigated whether ROS/RhoA/PI3K/PKB pathway plays a key role in the process of the increase in BTB permeability induced by NS1619. The results revealed that the BTB permeability was increased and the expression of TJ proteins were significantly decreased by NS1619, and selective inhibitors of identified signaling pathways reversed the observed alterations. Moreover, the significant increases in ROS, RhoA activity, and PKB phosphorylation after NS1619 administration were observed, which were partly inhibited by N-2-mercaptopropionyl glycine or C3 exoenzyme or LY294002 pretreatment. The present study demonstrates that the activation of signaling cascades involving ROS/RhoA/PI3K/PKB in rat brain microvascular endothelial cells was required for the increase in BTB permeability induced by NS1619.
Similar content being viewed by others
References
Cooper I, Cohen-Kashi-Malina K, Teichberg VI (2011) Claudin-5 expression in in vitro models of the blood–brain barrier. Methods Mol Biol 762:347–354
Drappatz J, Schiff D, Kesari S, Norden AD, Wen PY (2007) Medical management of brain tumor patients. Neurol Clin 25:1035–1071
Furuse M, Sasaki H, Fujimoto K, Tsukita S (1998) A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 143:391–401
Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K (2001) Molecular and cellular permeability control at the blood–brain barrier. Brain Res Rev 36:258–264
Gu YT, Xue YX, Wei XY, Zhang H, Li Y (2011) Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats. Neurosci Lett 493(3):140–144
Harhaj NS, Antonetti DA (2004) Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36(7):1206–1237
Hayashi Y, Yoshida Y, Hamada J (2006) Blood-tumor barrier in malignant brain tumor. No Shinkei Geka 34:983–999
Heinen A, Camara AK, Aldakkak M, Rhodes SS, Riess ML, Stowe DF (2007) Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol 292:C148–C156
Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR (2010) Cellular mechanisms of IL-17-induced blood–brain barrier disruption. FASEB J 24(4):1023–1034
Hurst RD, Fritz IB (1996) Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood–brain barrier. J Cell Physiol 167:81–88
Ivanov AI, McCall IC, Parkos CA, Nusrat A (2004) Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol Biol Cell 15(6):2639–2651
Jou TS, Schneeberger EE, Nelson WJ (1998) Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases. J Cell Biol 142:101–115
Kicinska A, Szewczyk A (2004) Large-conductance potassium cation channel opener NS1619 inhibits cardiac mitochondria respiratory chain. Toxicol Mech Methods 14(1–2):59–61
Komarova Y, Malik AB (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72:463–493
Massoumi R, Sjolander A (1998) The inflammatory mediator leukotriene D4 triggers a rapid reorganisation of the actin cytoskeleton in human intestinal epithelial cells. Eur J Cell Biol 76:185–191
Ningaraj NS, Rao M, Hashizume K, Asotra K, Black KL (2002) Regulation of blood–brain tumor barrier permeability by calcium-activated potassium channels. J Pharmacol Exp Ther 301:838–851
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice. J Cell Biol 161:653–660
Nusrat A, Chen JA, Foley CS, Liang TW, Tom J, Cromwell M, Quan C, Mrsny RJ (2000) The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem 275:29816–29822
Perriere N, Demeuse P, Garcia E, Regina A, Debray M, Andreux JP, Couvreur P, Scherrmann JM, Temsamani J, Couraud PO, Deli MA, Roux F (2005) Puromycinbased purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier-specific properties. J Neurochem 93:279–289
Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T (2006) Rho-mediated regulation of tight junctions during monocyte migration across blood–brain barrier in HIV-1 encephalitis (HIVE). Blood 107:4770–4780
Prasad R, Giri S, Nath N, Singh I, Singh AK (2005) Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial- monocyte cell interaction. J Neurochem 94:204–214
Pun PB, Lu J, Moochhala S (2003) Involvement of ROS in BBB dysfunction. Free Radic Res 43:348–364
Salama NN, Eddington ND, Fasano A (2006) Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev 58(1):15–28
Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21:3666–3676
Scott PA, Bicknell R (1993) The isolation and culture of microvascular endothelium. J Cell Sci 105(Pt 2):269–273
Shen L, Turner JR (2005) Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell 16:3919–3936
Spindler V, Schlegel N, Waschke J (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87(2):243–253
Vandenbroucke E, Mehta D, Minshall R, Malik AB (2008) Regulation of endothelial Junctional permeability. Ann N Y Acad Sci 1123:134–145
Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ (2001) Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114(Pt 7):1343–1355
Wolburg H, Lippoldt A (2002) Tight junctions of the blood–brain barrier: development, composition and regulation. Vascul Pharmacol 38:323–337
Xie H, Xue YX, Liu LB, Liu YH, Wang P (2012) Role of RhoA/ROCK Signaling in Endothelial-Monocyte-Activating Polypeptide II Opening of the Blood-Tumor Barrier: Role of RhoA/ROCK Signaling in EMAP II Opening of the BTB. J Mol Neurosci 46:666–676
Acknowledgments
This work was supported by Doctor-Beginning Science Foundation of Liaoning Province, no. 20101109; Specialized Research Fund for the Doctoral Program of Higher Education, no. 20102134120007; National Science Foundation for China, nos. 81100924 and 81101912; and Doctor-Beginning Science Foundation of HeBei affiliation University, no. BS09012.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Y.-T. Gu and Y.-X. Xue contributed equally to this work.
Rights and permissions
About this article
Cite this article
Gu, YT., Xue, YX., Wang, YF. et al. Role of ROS/RhoA/PI3K/PKB Signaling in NS1619-Mediated Blood–Tumor Barrier Permeability Increase. J Mol Neurosci 48, 302–312 (2012). https://doi.org/10.1007/s12031-012-9789-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-012-9789-2